OCI Chemical
OCI Company Ltd., established in 1959 and headquartered in Seoul, South Korea, is a green energy and chemical firm known for its commitment to sustainable practices. The company specializes in the development, construction, financing, and operation of utility-scale solar power facilities, catering to both utility and distributed generation markets. OCI is dedicated to providing reliable and sustainable energy solutions, contributing to the electric power generation, transmission, and distribution sectors. Through its initiatives, OCI aims to enhance energy accessibility and support communities with clean energy alternatives.
Top Regions
2 past transactions
SN BioScience
Series B in 2020
SN BioScience specializes in nano-formulation screening services aimed at enhancing the delivery of small molecules, oligonucleotides, peptides, and proteins. Utilizing its proprietary double core-shell technology, the company focuses on developing innovative drug delivery systems, particularly for cancer therapeutics. By employing a diverse range of lipids and polymers, SN BioScience addresses challenges related to solubility and delivery of poorly soluble drugs, enabling clients to create stable nano-sized micelles, nanoparticles, or liposomes. This approach not only fosters research advancement but also opens significant opportunities for the development of novel oncology products.
SN BioScience
Series A in 2019
SN BioScience specializes in nano-formulation screening services aimed at enhancing the delivery of small molecules, oligonucleotides, peptides, and proteins. Utilizing its proprietary double core-shell technology, the company focuses on developing innovative drug delivery systems, particularly for cancer therapeutics. By employing a diverse range of lipids and polymers, SN BioScience addresses challenges related to solubility and delivery of poorly soluble drugs, enabling clients to create stable nano-sized micelles, nanoparticles, or liposomes. This approach not only fosters research advancement but also opens significant opportunities for the development of novel oncology products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.